IMJ995
/ Novartis
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
December 21, 2022
CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia
(clinicaltrials.gov)
- P1 | N=0 | Withdrawn | Sponsor: Novartis Pharmaceuticals | N=35 ➔ 0 | Not yet recruiting ➔ Withdrawn
CAR T-Cell Therapy • Enrollment change • Trial withdrawal • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology • CD19 • CD22
December 15, 2022
Study of IMJ995 in kids and adults with Acute Lymphoblastic Leukemia
(clinicaltrialsregister.eu)
- P1 | N=35 | Sponsor: Novartis Pharma AG
New P1 trial • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology • CD19 • CD22
September 09, 2022
CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia
(clinicaltrials.gov)
- P1 | N=35 | Not yet recruiting | Sponsor: Novartis Pharmaceuticals | Trial completion date: Mar 2026 ➔ Jul 2026 | Trial primary completion date: Mar 2026 ➔ Jul 2026
CAR T-Cell Therapy • Trial completion date • Trial primary completion date • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology • CD19 • CD22
June 16, 2022
CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia
(clinicaltrials.gov)
- P1 | N=35 | Not yet recruiting | Sponsor: Novartis Pharmaceuticals | Trial completion date: Dec 2025 ➔ Mar 2026 | Initiation date: Sep 2022 ➔ Dec 2022 | Trial primary completion date: Dec 2025 ➔ Mar 2026
CAR T-Cell Therapy • Trial completion date • Trial initiation date • Trial primary completion date • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology • CD19 • CD22
February 18, 2022
CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia
(clinicaltrials.gov)
- P1 | N=35 | Not yet recruiting | Sponsor: Novartis Pharmaceuticals | Trial completion date: Jul 2025 ➔ Oct 2025 | Initiation date: Mar 2022 ➔ Jul 2022 | Trial primary completion date: Jul 2025 ➔ Oct 2025
CAR T-Cell Therapy • Trial completion date • Trial initiation date • Trial primary completion date • Acute Lymphocytic Leukemia • Hematological Malignancies • Leukemia • Oncology • CD19 • CD22
1 to 5
Of
5
Go to page
1